Citation

Pérez-Esparza R, Corona T, Ruiz-García RG, Oñate-Cadena N, de la Fuente-Sandoval C, Ramirez-Bermudez J. Psychiatry Clin. Neurosci. 2018; 72(8): 623.

Affiliation

Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

Copyright

(Copyright © 2018, John Wiley and Sons)

DOI

10.1111/pcn.12675

PMID

29744959

Abstract

Growing evidence of the rapid antidepressant effects of ketamine represents a promising advance in treatment-resistant depression (TRD) therapeutics. Most studies provide information after treatment washout, reporting response up to 7 days and remission up to 3-5 days after a single dose.

This article is protected by copyright. All rights reserved.

Language: en